TransEnterix Receives CE Mark for Machine Vision System in Robotic Surgery
(NYSE American:TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced the Company received CE Mark approval for the Intelligent Surgical Unit TM (ISU TM ) that enables machine vision capabilities on the Senhance Ⓡ Surgical System.
(NYSE American:TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced the Company received CE Mark approval for the Intelligent Surgical Unit TM (ISU TM ) that enables machine vision capabilities on the Senhance Ⓡ Surgical System.
interface, patient, Senhance, TRXC, machine vision capabilities, CE Mark approval, medical device company, Surgical System, Intelligent Surgical Unit TM, ISU TM, invasive surgery, NYSE American
